View Older Stories View More Recent Stories

Mar 27, 2019 08:00AM Mirum Pharmaceuticals to Present Phase 2 Clinical Results of Maralixibat in Alagille Syndrome and Progressive Familial Intrahepatic Cholestasis at the International Liver Congress
Mar 26, 2019 07:00AM Arvinas Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Corporate Update
Mar 26, 2019 07:00AM Arvinas Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Corporate Update
Mar 21, 2019 08:00AM Mirum Pharmaceuticals Appoints Chris Peetz as Chief Executive Officer
Mar 14, 2019 07:00AM Neos Therapeutics Reports Fourth Quarter and Year-End 2018 Financial Results
Mar 13, 2019 08:00AM Harvard and Deerfield Establish Lab1636, a Major Translational Research Alliance
Mar 13, 2019 08:00AM Harvard and Deerfield establish Lab1636, a major translational research alliance
Mar 13, 2019 07:30AM TriNetX Secures $40 Million in Series D Funding
Mar 11, 2019 08:00AM Bridge Medicines Enters Agreement with Weill Cornell Medicine to Develop a Novel Sphingosine 1-Phosphate (S1P) Receptor Modulator
Mar 11, 2019 07:30AM Nuvo Pharmaceuticals™ Announces Receipt of Shareholder Approval By Way of Written Consent For the Issuance of Common Shares Pursuant to Convertible Notes and Warrants
Feb 27, 2019 10:15AM Itamar Medical to Commence Trading on Nasdaq
Feb 26, 2019 10:12AM Deerfield and Oxeon Join Forces with HLTH to Connect Healthcare Leaders with Qualified Female Board Candidates
Feb 25, 2019 08:15AM Melinta Therapeutics Announces Closing of Initial $75 Million Vatera Convertible Loan Funding
Feb 25, 2019 08:15AM Melinta Therapeutics Announces Closing of Initial $75 Million Vatera Convertible Loan Funding
Feb 21, 2019 01:31PM Melinta Therapeutics (MLNT) Board Approves 1-for-5 Reverse Stock Split
Feb 21, 2019 01:30PM Melinta Therapeutics Announces One-for-Five Reverse Stock Split
Feb 21, 2019 01:30PM Melinta Therapeutics Announces One-for-Five Reverse Stock Split
Feb 14, 2019 06:29PM Form 13F-HR DEERFIELD MANAGEMENT For: Dec 31
Feb 12, 2019 09:04AM Adeptus Health Appoints James Hopwood as its Chief Financial Officer
Feb 7, 2019 04:15PM Axovant Announces Third Fiscal Quarter 2018 Financial Results and Corporate Updates
Feb 6, 2019 08:00AM Deerfield Management Advanced Healthcare Initiatives Globally Through Academic Collaborations, Publications, and Philanthropy
Feb 4, 2019 06:00PM CathWorks Announces Completion of $30 Million Financing
Feb 4, 2019 08:07AM Melinta Therapeutics (MLNT) Provides Updates on Strategic Repositioning Initiatives, Cost Savings Outlook
Feb 4, 2019 08:00AM Melinta Therapeutics Provides Corporate Updates
Feb 4, 2019 08:00AM Melinta Therapeutics Provides Corporate Updates
Jan 17, 2019 09:00AM Itamar Medical Announces Definitive Agreements for $11.5 Million Private Placement
Jan 10, 2019 07:30AM FTI Consulting’s Corporate Finance & Restructuring Segment Wins Several Industry Awards
Jan 10, 2019 07:30AM FTI Consulting’s Corporate Finance & Restructuring Segment Wins Several Industry Awards
Jan 8, 2019 07:45AM Johnson & Johnson Innovation to Join NXT Biomedical Therapeutic Device Incubator to Accelerate Medical Device Innovation
Jan 8, 2019 05:00AM PQ Bypass Announces $60 Million Financing to Advance New Therapeutic Approach to Peripheral Arterial Disease
Jan 7, 2019 08:00AM Stelexis Therapeutics Closes $43 million Series A to Expand Novel Platform Focused on Cancer Interception
Jan 4, 2019 07:00AM Ribon Therapeutics Raises $65 Million to Advance Pipeline of Novel Therapeutics Targeting Cellular Stress Pathways for Cancer
Jan 3, 2019 08:00AM Cabaletta Bio Closes $50 Million Series B Financing to Establish Translational Research and Advanced Manufacturing Capabilities for Chimeric AutoAntibody Receptor (CAAR) T Cell Products to Treat B Cel
Jan 3, 2019 08:00AM Cabaletta Bio Closes $50 Million Series B Financing to Establish Translational Research and Advanced Manufacturing Capabilities for Chimeric AutoAntibody Receptor (CAAR) T Cell Products to Treat B Cel
Jan 3, 2019 07:00AM Axovant Announces Presentation at J.P. Morgan Healthcare Conference and Anticipated 2019 Clinical Development Milestones
Jan 2, 2019 07:30AM Nuvo Pharmaceuticals™ to Host Conference Call/Audio Webcast to Discuss the Acquisition of Aralez Pharmaceuticals Canada, U.S. and International Rights to Vimovo® and other Related Assets
Dec 31, 2018 11:26AM Nuvo Pharmaceuticals™ Announces Completion of the Acquisition of Aralez Pharmaceuticals Canada, U.S. and International Rights to Vimovo® and other Related Assets
Dec 19, 2018 08:00AM ARS Pharmaceuticals Advances Clinical Program for Intranasal Epinephrine Spray
Nov 29, 2018 09:00AM Nuvo Pharmaceuticals™ Declared Winning Bidder to Acquire Commercial Products from Aralez Pharmaceuticals
Nov 29, 2018 09:00AM Aralez Pharmaceuticals to Seek Court Approval of Previously Announced "Stalking Horse" Transactions for Substantially All Assets
Nov 28, 2018 07:00AM Oncorus Announces Nomination of ONCR-177, A Next-Generation Oncolytic Virus Therapy Clinical Candidate for Multiple Solid Tumor Indications
Nov 27, 2018 04:00PM SHINE And Deerfield Close $150 Million Financing Commitment To Support Diagnostic And Therapeutic Medical Isotope Manufacturing
Nov 14, 2018 05:06PM Form 13F-HR DEERFIELD MANAGEMENT For: Sep 30
Nov 13, 2018 09:00AM Citco Launches New SaaS Æxeo Treasury™ Solution on Amazon Web Services
Nov 13, 2018 08:00AM Dana-Farber Cancer Institute and Deerfield Collaborate to Create the Center for Protein Degradation
Nov 13, 2018 06:00AM Citco Launches New SaaS Æxeo Treasury™ Solution on Amazon Web Services
Nov 9, 2018 07:00AM Neos Therapeutics Reports Third Quarter 2018 Financial Results
Nov 8, 2018 08:05AM InCarda Therapeutics Provides Corporate Update Highlighting Fundraising and Clinical Development Milestones
Nov 8, 2018 07:30AM Nuvo Pharmaceuticals™ Announces 2018 Third Quarter Results
Nov 7, 2018 07:00AM Mirum Pharmaceuticals Secures $120 Million in Series A Financing to Develop Phase 3-Ready Maralixibat for Rare Liver Diseases
View More Recent Stories View Older Stories